From: Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAs
Parameter | PCa | BPH |
---|---|---|
Total patient number | 50 | 30 |
Age at surgery [years] | Â | Â |
 Median (range) | 65 (49 – 78) | 72 (50 – 86) |
Pre-operative PSA [ng/ml] | Â | Â |
 Median (range) | 10.2 (2.8 – 113.0) | 2.6 (0.2 – 46.2) |
 | n (%) |  |
Tumor stage | Â | Â |
 pT2 (organ-confined) | 23 (46%) | - |
 pT3 + 4 (nonorgan-confined) | 27 (54%) | - |
Gleason score | Â | Â |
 < 7 (low) | 16 (32%) | - |
 7 (intermediate) | 19 (38%) | - |
 > 7 (high) | 15 (30%) | - |
Lymph node status | Â | Â |
 N0 | 43 (86%) | - |
 N+ | 7 (14%) | - |
Distant metastases at prostatectomy | Â | |
 M0 | 46 (92%) | - |
 M+ | 4 (8%) | - |
Initial metastases | Â | Â |
 N0M0 | 40 (80%) | - |
 N+/M+ | 10 (20%) | - |